谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

DYNC2H1 Mutation As a Potential Predictive Biomarker for Immune Checkpoint Inhibitor Efficacy in NSCLC and Melanoma.

Lu Yang, Yanlong Feng, Xuewen Liu, Qin Zhang, Yaqin Liu,Xing Zhang,Ping Li,Dongsheng Chen

Investigational New Drugs（2025）

引用 0|浏览2
关键词
DYNC2H1 mutation,ICI treatment efficacy,Biomarker,NSCLC,Melanoma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要